We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Funding Bill Seeks Answers From FDA On Proposed Generic Drug Labeling
House Funding Bill Seeks Answers From FDA On Proposed Generic Drug Labeling
House lawmakers advanced an FDA funding package that directs the agency to address a multitude of controversial issues, including justifying the costs to generic drugmakers of the agency’s proposed labeling overhaul.